Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 26, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

Performance of a New HPV Cervi-Collect Collection and Transportation Kit.

M Chernesky1, S Huang, D Jang

  • 1St. Joseph's Healthcare Hamilton, McMaster University, Hamilton, ON, Canada L8N 4A6.

Journal of Oncology
|December 17, 2011
PubMed
Summary

The new Cervi-Collect kit for human papillomavirus (HPV) testing shows high agreement with traditional liquid-based Pap (L-Pap) media. This HPV testing method is easy to use and safe for healthcare collectors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Emergence of the isotropic Kitaev honeycomb latticeα-RuCl<sub>3</sub>and its magnetic properties.

Journal of physics. Condensed matter : an Institute of Physics journal·2024
Same author

[Febrile dyspnea in a 20 year-old woman].

La Revue de medecine interne·2023
Same author

High-precision measurement of the <i>W</i> boson mass with the CDF II detector.

Science (New York, N.Y.)·2022
Same author

Probing the Effects of Strong Electromagnetic Fields with Charge-Dependent Directed Flow in Pb-Pb Collisions at the LHC.

Physical review letters·2020
Same author

Evidence of stage progression in a novel, validated fluorescence-navigated and microsurgical-assisted secondary lymphedema rodent model.

PloS one·2020
Same author

Evidence of Spin-Orbital Angular Momentum Interactions in Relativistic Heavy-Ion Collisions.

Physical review letters·2020

Area of Science:

  • Gynecologic Oncology
  • Molecular Diagnostics
  • Public Health

Background:

  • Liquid-based Pap (L-Pap) media are standard for Pap and human papillomavirus (HPV) testing.
  • Accurate HPV detection is crucial for cervical cancer screening and prevention.

Purpose of the Study:

  • To compare the performance of a new collection kit, Cervi-Collect, with established L-Pap media for high-risk HPV (HR HPV) testing.
  • To evaluate the ease of use and safety of the Cervi-Collect system.

Main Methods:

  • 203 L-Pap samples were tested using both HC2 and RealTime High Risk (HR) HPV assays.
  • Cervi-Collect specimens were tested using the RealTime HR HPV assay.
  • Discordant results were further analyzed through genotyping.

More Related Videos

Use of Interferon-&gamma; Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

Related Experiment Videos

Last Updated: May 26, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

Use of Interferon-&gamma; Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

Main Results:

  • RealTime HR HPV testing demonstrated 93.1% agreement between L-Pap and Cervi-Collect specimens (Kappa 0.86).
  • High agreement (90.3%, Kappa 0.80) was observed between RealTime HR HPV and HC2 assays on L-Pap specimens.
  • RealTime HR HPV on Cervi-Collect and HC2 on L-Pap showed 88.2% agreement (Kappa 0.76).
  • Genotyping confirmed HR HPV in 16 of 21 discordant samples, validating the assays' ability to detect relevant genotypes.

Conclusions:

  • The Cervi-Collect collection kit is a user-friendly and safe option for HR HPV testing.
  • Cervi-Collect specimens exhibit strong concordance with L-Pap samples, supporting its utility in clinical settings.
  • This new kit offers a reliable alternative for HPV testing, potentially improving cervical cancer screening accessibility.